NRXP

NRx Pharmaceuticals, Inc. NRXP

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode NRXP CUE OTLK SPRB COEP HOWL EQ KPTI IOBT IPSC
6M -24.58 % -64.72 % -77.34 % 870.05 % 29.55 % -59.31 % 177.18 % 50.96 % -73.43 % 262.88 %
YTD -13.36 % -10.49 % -17.24 % -18.93 % -13.46 % -14.81 % -24.84 % -12.24 % -25.18 % 118.11 %
1Y -46.71 % -76.41 % -75.06 % 155.93 % 32.53 % -59.01 % 64.31 % -39.73 % -37.94 % 139.73 %
3Y -83.06 % -91.01 % -97.87 % -63.00 % -66.83 % -84.35 % 6.48 % -86.47 % -79.75 % -52.10 %
5Y -99.30 % -97.94 % -97.83 % -95.66 % -93.80 % -96.59 % -79.13 % -97.21 % -96.79 % -90.49 %
10Y -97.64 % -97.40 % -99.92 % -94.23 % -93.60 % -96.59 % -91.79 % -93.41 % -96.79 % -90.49 %
From the beginning -97.64 % -97.40 % -99.92 % -94.23 % -93.60 % -96.59 % -91.79 % -97.38 % -96.79 % -90.49 %

Dividend